In partnership with Optum Labs, Oshi Health’s landmark clinical trial demonstrated the effectiveness of virtual multidisciplinary GI care in improving clinical outcomes and reducing healthcare utilization and costs.

With total medical and Rx savings of $10,292 in the first six months, Oshi Health’s study exhibits the highest per patient cost savings in the digestive health industry.

Oshi’s landmark study

This validated study demonstrates how Oshi’s unique, integrated approach improves access and accelerates diagnosis driving high rates of symptom control and patient satisfaction.

  • 92%
    of Oshi patients achieved symptom control in under 4 months
  • 98%
    satisfaction among Oshi GLP-1 patients
  • 47%
    fewer missed work days

Based on a match control analysis with Optum Labs, the study demonstrated significant reductions in utilization and costs – a 5x ROI.

  • $10K
    total savings per patient in six months (p<0.0001)
  • 57%
    reduction in GI-related imaging (p<0.0001)
  • 62%
    reduction in GI-related ER visits (p<0.0001)

Expanding access to Oshi unlocks significant savings across the healthcare ecosystem – for patients, providers, health plans, and employers alike.

Download the full report



Oshi health has changed my life! I have not felt this great in 24 years. I would have never been able to manage my health if it wasn't for my care team!

— Oshi patient

While this study looks at patients with IBS and who are undiagnosed, Oshi’s model is built to treat all GI issues across the condition and acuity spectrum. Check out our other research to see our proven impact at scale.

Related Article

2024 Oshi Health Impact Report

Read More

Get in touch